CASR and autosomal dominant hypocalcemia: In Western cohorts, CASR gain-of-function mutations are among the most frequently reported causes of autosomal dominant hypocalcemia, whereas GCM2 mutations are relatively rare but have been described in Latin American and South Asian families, sometimes linked to founder effects [31,32,33,34].